Shasqi
Pre-clinicalShasqi uses click chemistry to target cancer drugs directly to the tumor, minimizing side effects and potentially improving the therapeutic index
Founded
2014
Focus
Drug Delivery
About
Shasqi uses click chemistry to target cancer drugs directly to the tumor, minimizing side effects and potentially improving the therapeutic index
Funding History
2Total raised: $38.5M
Series A$35MLux CapitalFeb 15, 2021
Seed$3.5MY CombinatorMay 15, 2018
Company Info
TypePrivate
Founded2014
LocationSan Francisco, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile